Maria Papaleontiou is an Endocrinology/Metabolic physician affiliated with University of Michigan. OpenAlex indexes 115 publications with 2,352 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
24 Frank Lloyd Wright Dr
Lobby C Suite 1300
Ann Arbor, MI 481059484
Telephone
734-647-5871Registry record last updated 31 Jul 2013.
Clinical trials
- Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
91.9%l-Thyroxine91.9%Levothyroxine Sodium57%Levoxyl29%Synthroid14%Part D<11 patientsSensory organs
8.1%Corticosteroid8.1%Hydrocortisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2016–2025 per NIH RePORTER. The latest:
- Optimizing Care for Older Adults through Thyroid Hormone Deprescribing
University of Michigan at Ann Arbor
FY2025$2,206,807RF1AG079833 - Optimizing Care for Older Adults through Thyroid Hormone Deprescribing
University of Michigan at Ann Arbor
FY2024$766,055R01AG079833 - Optimizing Care for Older Adults through Thyroid Hormone Deprescribing
University of Michigan at Ann Arbor
FY2023$795,722R01AG079833
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Physician‐reported barriers and facilitators to thyroid hormone deprescribing in older adults
Journal of the American Geriatrics Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Matthias Kretzler, MD
University of Michigan
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”